Andrew J. Murphy

2019

In 2019, Andrew J. Murphy earned a total compensation of $9.5M as Executive Vice President, Research at Regeneron Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$666,900
Option Awards$3,526,669
Salary$600,000
Stock Awards$4,702,308
Other$23,470
Total$9,519,347

Murphy received $4.7M in stock awards, accounting for 49% of the total pay in 2019.

Murphy also received $666.9K in non-equity incentive plan, $3.5M in option awards, $600K in salary and $23.5K in other compensation.

Rankings

In 2019, Andrew J. Murphy's compensation ranked 814th out of 13,971 executives tracked by ExecPay. In other words, Murphy earned more than 94.2% of executives.

ClassificationRankingPercentile
All
814
out of 13,971
94th
Division
Manufacturing
284
out of 5,692
95th
Major group
Chemicals And Allied Products
79
out of 2,189
96th
Industry group
Drugs
65
out of 1,875
97th
Industry
Pharmaceutical Preparations
53
out of 1,387
96th
Source: SEC filing on April 24, 2020.

Murphy's colleagues

We found four more compensation records of executives who worked with Andrew J. Murphy at Regeneron Pharmaceuticals in 2019.

2019

Leonard Schleifer

Regeneron Pharmaceuticals

Chief Executive Officer

2019

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

2019

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

2019

Daniel Van Plew

Regeneron Pharmaceuticals

Executive Vice President and General Manager, Industrial Operations and Product Supply

News

You may also like